The development of the Mental Health Confidence Scale: A measure of self-efficacy in individuals diagnosed with mental disorders.

Psychiatric Rehabilitation Journal (Impact Factor: 1.16). 10/2012; DOI: 10.1037/h0095162

ABSTRACT This article discusses a new scale for the measurement of self-efficacy among persons dealing with mental disorders and examines the relationship between involvement in self-help and self-efficacy. The Mental Health Confidence Scale scale is based on theories of self-efficacy and recent qualitative research on self-help groups. It is designed to assess the self-efficacy beliefs of persons dealing with mental disorders, particularly how confident they are about their ability to deal with those things that commonly influence their lives. The presumed 3-factor structure of the scale (optimism, coping, advocacy) was tested using data from a study on understanding factors associated with participation and nonparticipation in mental health self-help groups; Ss were 554 self-help group participants, mean age 42 yrs. Results of confirmatory factor analyses support the 3-factor structure and suggest that the scale is a reliable means of assessing mental health related efficacy beliefs. In correlational analyses, generally positive associations were found between participation in self-help and self-efficacy. (PsycINFO Database Record (c) 2012 APA, all rights reserved)

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Individuals with serious mental illness (SMI) are at considerably higher risk for morbidity and mortality than those in the general population. The current pilot trial is a preliminary examination of a peer health navigation intervention for improving health and healthcare utilization called the Bridge. Twenty-four individuals with SMI were randomly assigned to either peer navigation or treatment as usual (TAU). Navigators encouraged development of self-management of healthcare through a series of psychoeducation and behavioral strategies. Outcomes included a range of health consequences, as well as health utilization indices. After 6 months, compared to the TAU group, participants receiving the intervention experienced fewer pain and health symptoms. Participants changed their orientation about seeking care to a primary care provider (44.4 % vs. 83.3 %, χ(2) = 3.50, p < .05) rather than the emergency room (55.6 % vs. 0 %, χ(2) = 8.75, p < .01). Therefore, the Bridge intervention demonstrated considerable promise through positively impacting health and healthcare utilization.
    Community Mental Health Journal 06/2013; · 1.03 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Substance misuse is usually associated with poorer psychiatric medication adherence among psychiatric patients. Identifying predictors of medication adherence among patients with dual psychiatric and substance misuse problems is important because poor adherence is associated with relapse and re-hospitalization. The subjects were patients newly admitted to a psychiatric outpatient program who were prescribed psychiatric medication from different providers during the six months prior to admission; all also had substance misuse histories (N=131). Confidential research interviews were conducted that included a modified Medication Adherence Rating Scale (MARS) and drug toxicologies. Age (mean): 39 y; male 61%; Black 41%; Hispanic 38%; White 21%; completed high school/GED 41%; DSM-IV diagnoses: major depression 26%, schizoaffective 21%, bipolar 16%, schizophrenia 13%, other 24%; positive drug toxiology 55%. Potentially malleable factors correlated with lower adherence were: lower friends' support for drug/alcohol abstinence, more recovery-promoting behaviors, lower satisfaction with medication, more medication side effects, lower self-efficacy for drug avoidance, and lower social support for recovery. In multivariate regression analysis, only the last three factors remained as significant predictors of adherence. Low adherence is not attributable to simply forgetting to take medication. Strengthening adherence should also include better education about side effects and the importance of adherence to sustain the benefits of medication. Psychiatrists and other medical providers should also be encouraged to address patients' adherence strategies, since the time devoted to addressing that during treatment may prevent serious adverse events such as relapse to substance abuse, treatment drop-out and re-hospitalization.
    The Open Addiction Journal 11/2011; 4:58-64.


Available from
Jun 4, 2014